Literature DB >> 19318133

The psychosocial impact of epilepsy in adults.

Bruce Hermann1, Ann Jacoby.   

Abstract

Although defined by the presence of recurrent seizures, epilepsy can be so much more and can include a very wide range of difficulties in cognition, psychiatric status, and social adaptive functioning. These psychosocial complications of epilepsy have a long history, generating calls for action by national commissions, public health agencies, and special action groups which are briefly summarized here. Next, a brief overview of the prevalence of psychosocial complications of epilepsy in population-based and other representative is presented. Finally, with a focus on the onset and development of psychosocial difficulties, the following points are stressed: (1) neurobiological factors likely contribute to psychosocial problems in a major way, but currently this contribution is poorly understood, and (2) although neurobiological factors may prove important, they operate in a social setting, and therefore, a full accounting of the etiology, treatment, and prevention of psychosocial problems in epilepsy will require an integrated biopsychosocial model and life span perspective.

Entities:  

Mesh:

Year:  2009        PMID: 19318133      PMCID: PMC3680516          DOI: 10.1016/j.yebeh.2009.03.029

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  25 in total

1.  The social course of epilepsy: chronic illness as social experience in interior China.

Authors:  A Kleinman; W Z Wang; S C Li; X M Cheng; X Y Dai; K T Li; J Kleinman
Journal:  Soc Sci Med       Date:  1995-05       Impact factor: 4.634

2.  The social and economic impact of epilepsy in Zambia: a cross-sectional study.

Authors:  Gretchen Birbeck; Elwyn Chomba; Masharip Atadzhanov; Edward Mbewe; Alan Haworth
Journal:  Lancet Neurol       Date:  2007-01       Impact factor: 44.182

3.  Epilepsy familiarity, knowledge, and perceptions of stigma: report from a survey of adolescents in the general population.

Authors:  Joan K. Austin; Patricia Osborne Shafer; Jessica Beach Deering
Journal:  Epilepsy Behav       Date:  2002-08       Impact factor: 2.937

4.  MRI volume loss of subcortical structures in unilateral temporal lobe epilepsy.

Authors:  Dalin T Pulsipher; Michael Seidenberg; Jared J Morton; Elizabeth Geary; Joy Parrish; Bruce Hermann
Journal:  Epilepsy Behav       Date:  2007-11       Impact factor: 2.937

5.  Selective cognitive impairment during focal and generalized epileptiform EEG activity.

Authors:  J H Aarts; C D Binnie; A M Smit; A J Wilkins
Journal:  Brain       Date:  1984-03       Impact factor: 13.501

6.  Attitudes of GPs to the care of people with epilepsy.

Authors:  A K Thapar; N C Stott; A Richens; M Kerr
Journal:  Fam Pract       Date:  1998-10       Impact factor: 2.267

7.  Teachers' attitudes toward students with epilepsy: results of a survey of elementary and middle school teachers.

Authors:  Malachy Bishop; Barbara Slevin
Journal:  Epilepsy Behav       Date:  2004-06       Impact factor: 2.937

8.  Psychiatric comorbidity in epilepsy: a population-based analysis.

Authors:  Jose F Tellez-Zenteno; Scott B Patten; Nathalie Jetté; Jeanne Williams; Samuel Wiebe
Journal:  Epilepsia       Date:  2007-07-28       Impact factor: 5.864

9.  The nature and course of neuropsychological morbidity in chronic temporal lobe epilepsy.

Authors:  T O Oyegbile; C Dow; J Jones; B Bell; P Rutecki; R Sheth; M Seidenberg; B P Hermann
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

10.  Perceptions of control in adults with epilepsy.

Authors:  S Gehlert
Journal:  Epilepsia       Date:  1994 Jan-Feb       Impact factor: 5.864

View more
  17 in total

1.  Behavioral implications of temporal lobe epilepsy on social contingency.

Authors:  James Fraser Rini; Juan Ochoa
Journal:  Epilepsy Behav       Date:  2020-06-22       Impact factor: 2.937

Review 2.  Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan.

Authors:  Jack J Lin; Marco Mula; Bruce P Hermann
Journal:  Lancet       Date:  2012-09-29       Impact factor: 79.321

3.  Deciding When Less Is More: The Crossroads of Withdrawing Antiepileptic Drugs.

Authors:  Naymee Velez Ruiz
Journal:  Epilepsy Curr       Date:  2018 Jan-Feb       Impact factor: 7.500

Review 4.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

5.  Distinct gene expression profiles directed by the isoforms of the transcription factor neuron-restrictive silencer factor in human SK-N-AS neuroblastoma cells.

Authors:  Stuart G Gillies; Kate Haddley; Sylvia A Vasiliou; Gregory M Jacobson; Bengt von Mentzer; Vivien J Bubb; John P Quinn
Journal:  J Mol Neurosci       Date:  2010-07-23       Impact factor: 3.444

6.  Stroke-related stigma among West Africans: Patterns and predictors.

Authors:  Fred Stephen Sarfo; Michelle Nichols; Suparna Qanungo; Abeba Teklehaimanot; Arti Singh; Nathaniel Mensah; Raelle Saulson; Mulugeta Gebregziabher; Uvere Ezinne; Mayowa Owolabi; Carolyn Jenkins; Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2017-02-09       Impact factor: 3.181

7.  The stigma scale for chronic illnesses 8-item version (SSCI-8): development, validation and use across neurological conditions.

Authors:  Yamile Molina; Seung W Choi; David Cella; Deepa Rao
Journal:  Int J Behav Med       Date:  2013-09

Review 8.  Stigma in epilepsy.

Authors:  Kirsten M Fiest; Gretchen L Birbeck; Ann Jacoby; Nathalie Jette
Journal:  Curr Neurol Neurosci Rep       Date:  2014-05       Impact factor: 5.081

9.  Satisfaction with life domains in people with epilepsy.

Authors:  Rosemarie Kobau; Cecily Luncheon; Matthew M Zack; Ross Shegog; Patricia H Price
Journal:  Epilepsy Behav       Date:  2012-11-13       Impact factor: 2.937

Review 10.  Genetic testing in the epilepsies-developments and dilemmas.

Authors:  Annapurna Poduri; Beth Rosen Sheidley; Sara Shostak; Ruth Ottman
Journal:  Nat Rev Neurol       Date:  2014-04-15       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.